Daily dividend news for investors in dividend stocks

Yield10 Bioscience, Inc. (YTEN) CEO Oliver Peoples on Q2 2018 Results - Earnings Call Transcript

Published Thu, 09 Aug 2018 21:48:03 -0400 on Seeking Alpha

Yield10 Bioscience, Inc. (Nasdaq: YTEN) Q2 2018 Results Earnings Conference Call August 9, 2018 4:30 PM ET
Lynne Brum - VP, Planning and Corporate Communications
Oliver Peoples - President and CEO
Kristi Snell - VP, Research and CSO
James Jang - Maxim Group
Greetings and welcome to the Second Quarter 2018 Financial Results and Business Update Conference Call for Yield10 Bioscience. During the call, participants will be in a listen-only mode. The presenters will address questions from an analyst today. [Operator Instructions] As a reminder, this conference call is being recorded.
I would now like to turn the conference call over to your host, Yield10 Vice President of Planning and Corporate Communications, Ms. Lynne Brum.
Lynne Brum
Thank you, Tim and good afternoon everyone. Welcome to the Yield10 Bioscience second quarter 2018 conference call. Joining me on the call today are President and CEO, Dr. Oliver Peoples; Vice President of Research and Chief Science Officer, Dr. Kristi Snell; and soon to be joining us Chief Accounting Officer, Chuck Haaser.
Earlier this afternoon, we issued our second quarter 2018 news release. This release, as well as slides to accompany our presentation today, are available on the Investor Relations section of our website at yield10bio.com.
Let’s now turn to slide two. Please note that as part of our discussion today, management will be making forward-looking statements.... Read more